Komori
Changes in Officers4599StemRIM Inc.Pharmaceuticals

Notice Regarding the Election of Director Candidates, Audit & Supervisory Board Members, and Substitute Audit & Supervisory Board Member Candidates

At the Annual General Meeting of Shareholders scheduled for 28 October 2026, the Company will propose increasing the number of directors by 1, from the current 4 to 5. The 3 Audit & Supervisory Board Members will be elected with the current number maintained, and 1 substitute Audit & Supervisory Board Member will also be elected.

Worth reading
41Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
1
people (increase in the number of directors)
Wording
Definitive
How definitive the wording is.

Who is moving to which position

Resolved 25 September 2026

Incoming appointee

3 items
Scheduled Appointment DateAt the conclusion of the 21st Annual General Meeting of Shareholders scheduled for 28 October 2026 (subject to approval of the election proposals at the shareholders' meeting)
Iida Zen (飯田 善)
Previous positionNot disclosed
New positionOutside Director
生年月日 15 February 1967入社年 Not disclosed
Okudaira Kazuyoshi (奥平 和良)
Previous positionAdvisor of the Company (current)
New positionOutside Audit & Supervisory Board Member
生年月日 1 May 1961入社年 2026
Kudo Yoji (久渡 庸二)
Previous positionFull-time Audit & Supervisory Board Member (outside) (the Company)
New positionAlternate Audit & Supervisory Board Member (outside)
生年月日 20 October 1948入社年 Not disclosed
Directors after the change5Number
Shareholders’ meeting approvalRequired. Proposals for the election of director candidates, Audit & Supervisory Board Member candidates and a substitute Audit & Supervisory Board Member candidate will be submitted to the 21st Annual General Meeting of Shareholders scheduled for 28 October 2026.
Reason for change

The proposal is to increase the number of directors by 1 and seek the election of 5 directors in order to support future business expansion and strengthen the risk management framework.

Who is moving to which position
ItemDetails
Resolution date25 September 2026
Scheduled Appointment DateAt the conclusion of the 21st Annual General Meeting of Shareholders scheduled for 28 October 2026 (subject to approval of the election proposals at the shareholders' meeting)
Name of appointeeIida Zen (飯田 善), Okudaira Kazuyoshi (奥平 和良), Kudo Yoji (久渡 庸二)
Appointee's new positionOutside Director, Outside Audit & Supervisory Board Member, Alternate Audit & Supervisory Board Member (outside)
Appointee's previous positionNot disclosed, Advisor of the Company (current), Full-time Audit & Supervisory Board Member (outside) (the Company)
Appointee's date of birth15 February 1967, 1 May 1961, 20 October 1948
Year the appointee joined the CompanyNot disclosed, 2026, Not disclosed
Reason for changeThe proposal is to increase the number of directors by 1 and seek the election of 5 directors in order to support future business expansion and strengthen the risk management framework.
Number of directors after the change5 (including 3 outside directors)
Subject to Approval by the General Meeting of ShareholdersRequired. Proposals for the election of director candidates, Audit & Supervisory Board Member candidates and a substitute Audit & Supervisory Board Member candidate will be submitted to the 21st Annual General Meeting of Shareholders scheduled for 28 October 2026.
Items this document does not state (11)
Date of departureNumber of shares held by the appointeeName of departing officerFormer position of departing officerNew position of departing officerReason for departureWhether the incumbent will remain in officeReasons for appointmentFiling as an independent officerDetails of organizational changesChange in Corporate Governance Structure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To support future business expansion and strengthen the risk management framework.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Election of Director Candidates, Audit & Supervisory Board Members, and Substitute Audit & Supervisory Board Member Candidates | StemRIM Inc. (4599) timely disclosure | Komori